GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike M who wrote (4099)	3/11/2002 11:51:10 PM
From: Mad2	Read Replies (1) of 5582

Oh Mike, if you quote, please be accurate Doesn't mean he has to buy into mad2's $18-24M proffering Here's what I wrote; Realistically its worth 24-32 mil max (assume 20%gp X 16 X 10) BTW Danny, 20% X 16 refers to a assumed EBITDA of .20 of sales times sales, with 10 being a high multiple, a more resonable mult is 7 which yealds roughly 24 mil. Figuring the value off what Gumm paid the bio-delivery guys one arrives at a figure ~40mil. I'd pay attention to the fact our dear friends Hensley and Davidson are taking cash and moving on. Hmmmmmm this whole Zicam thing was of their making and they'd rather have cash now, than stock or a piece of the business. What can we learn from that? mad2

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next